Multicentre, randomized research study to test the safety and efficacy of Foster® compared to Symbicort® on small airway function in patients with COPD (Chronic Obstructive Pulmonary Disease)

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To demonstrate the higher efficacy of small particles Foster® 100/6 (two puffs b.i.d.) versus large particles Symbicort® 200/6 (two inhalations b.i.d.), in terms of residual volume reduction in patients with Chronic Obstructive Pulmonary Disease.

Critère d'inclusion

Male or female patients aged more or equal than 40 years with Chronic Obstructive Pulmonary Disease

Liens

ictrp
euctr